title: C1-INH and C3/C4 levels do not correlate with long-term danazole dosage and HAE-1 attack-free interval.
authors.affiliation: Department of Dermatology and Allergology, University of Ulm, Maienweg 12, D-89081 Ulm, Germany. lars-alexander.schneider@medizin.uni-ulm.de
authors.forename: L A
authors.initials: LA
authors.lastname: Schneider
authors.forename: J
authors.initials: J
authors.lastname: Maetzke
authors.forename: G
authors.initials: G
authors.lastname: Staib
authors.forename: K
authors.initials: K
authors.lastname: Scharffetter-Kochanek
mesh_terms: D000799:Angioedema / Q000097:blood* / Q000188:drug therapy* / Q000235:genetics; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003174:Complement C1 Inactivator Proteins / Q000032:analysis; D003176:Complement C3 / Q000032:analysis; D003181:Complement C4 / Q000032:analysis; D003165:Complement System Proteins / Q000032:analysis*; D003613:Danazol / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D000893:Anti-Inflammatory Agents; D003174:Complement C1 Inactivator Proteins; D003176:Complement C3; D003181:Complement C4; D003165:Complement System Proteins; D003613:Danazol